Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2719 (LINC02719) is a long intergenic non-coding RNA (lincRNA), defined as a transcript longer than 200 nucleotides that does not overlap with protein-coding genes[1][3][7]. LincRNAs are thought to play diverse regulatory roles, including fine-tuning the expression of neighboring genes, modulating chromatin and genome architecture, stabilizing RNA, and regulating transcription, sometimes via enhancer-like mechanisms[3][5][7]. While the family of lincRNAs is known to be involved in gene regulation and may participate in various cellular processes, there is no specific evidence that LINC02719 itself acts directly as a therapeutic target, nor are there known drugs, mechanisms of action, or disease associations uniquely attributed to this lincRNA as of the current literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2719 (LINC02719).